Cargando…
Validating risk prediction models for multiple primaries and competing cancer outcomes in families with Li-Fraumeni syndrome using clinically ascertained data at a single institute
PURPOSE: There exists a barrier between developing and disseminating risk prediction models in clinical settings. We hypothesize this barrier may be lifted by demonstrating the utility of these models using incomplete data that are collected in real clinical sessions, as compared to the commonly use...
Autores principales: | Nguyen, Nam H., Dodd-Eaton, Elissa B., Corredor, Jessica L., Woodman-Ross, Jacynda, Green, Sierra, Hernandez, Nathaniel D., Gutierrez Barrera, Angelica M., Arun, Banu K., Wang, Wenyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10491358/ https://www.ncbi.nlm.nih.gov/pubmed/37693464 http://dx.doi.org/10.1101/2023.08.31.23294849 |
Ejemplares similares
-
LFSPROShiny: an interactive R/Shiny app for prediction and visualization of cancer risks in families with deleterious germline TP53 mutations
por: Nguyen, Nam H, et al.
Publicado: (2023) -
Li-Fraumeni Syndrome
por: Vogel, Wendy H.
Publicado: (2017) -
A pedigree-based prediction model identifies carriers of deleterious de novo mutations in families with Li-Fraumeni syndrome
por: Gao, Fan, et al.
Publicado: (2020) -
Hematologic malignancies and Li–Fraumeni syndrome
por: Swaminathan, Mahesh, et al.
Publicado: (2019) -
The first documentation of Li-Fraumeni syndrome in Korea.
por: Bang, Y. J., et al.
Publicado: (1995)